Chemical Biology Consortium Sweden

The Chemical Biology Consortium Sweden (CBCS) is a national infrastructure for chemical biology, a field of research where small molecules are used as tools to precisely study and manipulate biological processes.

High quality research in this area provides a critical foundation for developing novel tools and techniques to solve outstanding challenges in biology and biomedical sciences.

As such this research directly and significantly impacts important societal challenges, such as an aging patient population, escalating healthcare costs, antibiotic resistance, pandemic preparedness and not least a sustainable and competitive national Life Science landscape.The mission of CBCS is to provide excellent services to research groups throughout Sweden, and together identify, validate and use small molecules to explore biology.

CBCS enables high quality research, open access publications, and cross-fertilization between universities and industry.

To date CBCS has supported >230 individual users from all major Swedish universities, resulting in 156 publications and the founding of six Life Science companies.

CBCS is active in national outreach, supporting PhD and postdoc training and co-organizing  international conferences.CBCS is well-equipped to become a cutting-edge European infrastructure.

To achieve this potential CBCS applies for funding to: i) strengthen the core chemical biology infrastructure,ii) increase national presence and access,iii) enable data-driven chemical biology through state-of-the-art compound and disease profiling,iv) secure a Swedish membership of EU-OPENSCREEN.We also ask for funding to support two key areas of global interest:v) virus and infectious diseases andvi) precision medicine.CBCS activities are divided into nine modules detailed in the accompanying Description of the Infrastructure.

Taken together, this plan to strengthen CBCS will provide timely, globally competitive services to Swedish researchers, catalyzing innovation and discovery.